To ensure that Ca2+ ions indeed travel across the plasma membrane through the engineered ORAI1 channels, we introduced two inactivating mutations, the pore-dead E106A mutation and a dominant-negative mutation, R91W, that causes human severe combined immunodeficiency (SCID)36–38, into LOCa3. The gene discussed is ORAI1; the disease is severe combined immunodeficiency.